Navigation Links
Rosetta Genomics Announces Allowance of Two Additional microRNA Patents
Date:3/3/2008

Allowances Further Strengthen Company's Leading microRNA Intellectual

Property Position

Company's microRNA Patent Portfolio now Includes 2 Issued Patents, 2

Allowed Patents, and More Than 60 Pending Patent Applications

REHOVOT, Israel and NORTH BRUNSWICK, New Jersey, March 3 /PRNewswire-FirstCall/ -- Rosetta Genomics, Ltd. (NASDQ: ROSG) announced today that the U.S. Patent and Trademark Office (USPTO) has issued a Notice of Allowance for two of the company's patent applications on human (10/604,726) and viral (10/604,942) microRNAs. The first allowed patent application (10/604,726) is related to two clustered human hairpins and their related microRNAs. The second allowed patent application (10/604,942) is related to microRNA US5-1, a viral microRNA found in Human cytomegalovirus (HCMV), a member of the herpes virus family.

"Our leading intellectual property portfolio in microRNAs, which now includes two issued and two allowed patents, is a key component of our business strategy," said Amir Avniel, President and CEO of Rosetta Genomics. "Combining our proprietary microRNAs with microRNAs discovered in collaboration with Johns Hopkins University exclusively licensed to Rosetta Genomics, we believe we have exclusive access to the majority of known human and viral microRNA genes. In addition, we have in-licensed microRNAs from leading research institutes in this field. We believe this strong intellectual property position, will enable us to rapidly expand our pipeline and advance new microRNA-based diagnostics for a wide range of indications."

Rosetta Genomics has filed dozens of patent applications protecting composition-of-matter of human and viral microRNAs. These patent applications are related to hundreds of human and viral microRNAs sequences. The patent applications are directed to a wide range of variations, including mutations on the mature microRNA, the microRNAs' precursor and its predic
'/>"/>

SOURCE Rosetta Genomics Ltd
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Rosetta Genomics Announces Annual General Meeting of Shareholders to be Held on September 24, 2007
2. NYU Medical Center Collaborates With Rosetta Genomics to Develop a microRNA-Based Diagnostic Test for Melanoma
3. Rosetta Genomics to Present at the American Association of Cancer Research (AACR) "Molecular Diagnostics in Cancer Therapeutic Development" Conference
4. Rosetta Genomics to Webcast Presentation at Maxim Group Growth Conference
5. Rosetta Genomics to Host and Webcast its R&D Day on Friday, October 26, 2007
6. Rosetta Genomics Will Host and Webcast its R&D Day on Friday, October 26, 2007
7. Rosetta Genomics Announces Initiation of In Vivo Studies Following Successful Completion of First Milestone in MicroRNA-based Therapeutic Program for Liver Cancer
8. Rosetta Genomics Selects PCR as Platform for its microRNA-based Diagnostics to be Launched in 2008, Licensed Nanogens MGB Probe Technology
9. Rosetta Genomics and Columbia University Medical Center to Develop MicroRNA-based Diagnostics for Leukemia and Non Hodgkin Lymphoma
10. Rosetta Genomics Announces Initiation of Expansion of US Operations to Facilitate Expected Product Launches in 2008
11. Henry Ford Hospital and Rosetta Genomics to Develop MicroRNA-based Diagnostics for Brain Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/19/2014)... Sept. 19, 2014  Nektar Therapeutics (NASDAQ: ... studies characterizing the analgesic profiles of a series ... receptor agonist molecules. The preclinical research candidates were ... platform. The analgesic properties of kappa ... literature. 1,2 Kappa opioid receptors are expressed ...
(Date:9/19/2014)... September 19, 2014 Barnhardt Manufacturing ... Label for its Organic Cotton . The USDA ... of renewable biobased ingredients meets or exceeds levels set ... composed in whole or in significant part of agricultural, ... allow our Organic cotton to be immediately identified as ...
(Date:9/19/2014)... ROCKLAND, Massachusetts , September 19, 2014 ... with the 53rd European Society for Paediatric Endocrinology (ESPE) ... advancement of science and medical research in the field ... of Merck KGaA, Darmstadt, Germany , ... Growth Innovation (GGI) for 2014. The awards were announced ...
(Date:9/18/2014)... TX (PRWEB) September 18, 2014 ... integrated urological and interventional radiology products and services, ... known as cryotherapy and cryoablation) versus external beam ... Section of the American Urological Association (MAAUA) Annual ... , "Comparing Relative Effectiveness of Cryosurgery and External ...
Breaking Biology Technology:Nektar Presents Positive Preclinical Data on Oral, Peripherally-Acting Kappa Agonist Molecules at 2014 American Academy of Pain Management Meeting 2Nektar Presents Positive Preclinical Data on Oral, Peripherally-Acting Kappa Agonist Molecules at 2014 American Academy of Pain Management Meeting 3Nektar Presents Positive Preclinical Data on Oral, Peripherally-Acting Kappa Agonist Molecules at 2014 American Academy of Pain Management Meeting 4Nektar Presents Positive Preclinical Data on Oral, Peripherally-Acting Kappa Agonist Molecules at 2014 American Academy of Pain Management Meeting 5Barnhardt Manufacturing Company Earns USDA Certified Biobased Product Certification and Label for Organic Cotton 2EMD Serono Awards Grant for Growth Innovation (GGI) for the First Time 2EMD Serono Awards Grant for Growth Innovation (GGI) for the First Time 3HealthTronics Announces Data Comparing Cryotherapy Versus Radiation for Treating Prostate Cancer Poster Presented at the American Urological Association Regional Meeting 2
... and Webcast on May 9 at 8:00 a.m. PDT ... Inc.,(Nasdaq: HALO ), a biopharmaceutical company developing and ... the three months ended March 31, 2008., "This ... significantly advanced both,our partnered and proprietary programs in the ...
... May 8 Telik, Inc. (Nasdaq:,TELK) today reported a ... for,the first quarter ended March 31, 2008, compared with ... for the comparable period in 2007., For the ... were $10.6 million, compared with $18.0 million during the ...
... to ever increasing,cardiac toxicity found in market drugs, Gwathmey ... Cardionomics(TM) services,and the formation of its Cardionomics(TM) Advisory Board ... of drug candidates., Cardiac toxicity has played a ... over the past 30 years. It is estimated that ...
Cached Biology Technology:Halozyme Therapeutics Reports 2008 First Quarter Financial Results 2Halozyme Therapeutics Reports 2008 First Quarter Financial Results 3Halozyme Therapeutics Reports 2008 First Quarter Financial Results 4Halozyme Therapeutics Reports 2008 First Quarter Financial Results 5Halozyme Therapeutics Reports 2008 First Quarter Financial Results 6Halozyme Therapeutics Reports 2008 First Quarter Financial Results 7Halozyme Therapeutics Reports 2008 First Quarter Financial Results 8Halozyme Therapeutics Reports 2008 First Quarter Financial Results 9Telik Announces First Quarter 2008 Financial Results 2Telik Announces First Quarter 2008 Financial Results 3Increased Drug Related Cardiac Toxicity Leads Gwathmey Preclinical Testing Services to Create Novel Cardionomics(TM) Services for Preclinical Cardiac Safety Screening of Drug Candidates 2Increased Drug Related Cardiac Toxicity Leads Gwathmey Preclinical Testing Services to Create Novel Cardionomics(TM) Services for Preclinical Cardiac Safety Screening of Drug Candidates 3Increased Drug Related Cardiac Toxicity Leads Gwathmey Preclinical Testing Services to Create Novel Cardionomics(TM) Services for Preclinical Cardiac Safety Screening of Drug Candidates 4
(Date:9/19/2014)... evolve for the sake of fairness per se but ... so say Frans de Waal, PhD, and Sarah Brosnan, ... (IA), which is defined as a negative reaction to ... . , Their conclusion comes after the co-authors ... hypothesis that it is the evolution of forestalling partner ...
(Date:9/19/2014)... -- Nxt-ID, Inc. (Nasdaq: NXTD and NXTDW) ("Nxt-ID" ... m-commerce market, updates the "Wocket in Your Pocket" celebrity ad campaign, ... middleweight weight classes, Vinny Pazienza (PAZ). ... of Thrones actor Ciaran Hinds and Sons ... Katey Sagal have been cast in Bleed for This ...
(Date:9/18/2014)... Wash. - Washington State University researchers have developed a ... to power waste cleanup in rural areas. , ... to an inexpensive and quick way to clean up ... plants while reducing pollution. , Professor Haluk Beyenal ... of Engineering and Architecture discuss the system in the ...
Breaking Biology News(10 mins):Evolution of responses to (un)fairness 2Evolution of responses to (un)fairness 3NXT-ID's Vinny Paz Celebrity Ad Wocket Update: Katey Sagal and Ciaran Hinds Attached to His Upcoming Movie 2NXT-ID's Vinny Paz Celebrity Ad Wocket Update: Katey Sagal and Ciaran Hinds Attached to His Upcoming Movie 3Researchers develop unique waste cleanup for rural areas 2
... over face threats on many fronts: pollution, diseases, destructive fishing ... resistant to one potential menace seaweed than previously ... scientists from the United States and Australia. Their study ... individual reefs in all, more than 3,500 examinations of ...
... different species are likely to respond to climate change. ... species and the interactions between species, in the interest ... BioScience , by Eric Post of Pennsylvania State ... be avoided. Their approach, which relies on multi-stage analyses ...
... (June 1, 2009) The International Serious Adverse Events ... designed to discover genetic markers that may predict individuals ... The SAEC is a nonprofit research corporation, launched ... by 10 leading pharmaceutical companies and the Wellcome Trust. ...
Cached Biology News:In the turf war against seaweed, coral reefs more resilient than expected 2International Serious Adverse Events Consortium announces initial study results in its global research collaboration to identify genetic markers related to drug induced liver injury 2International Serious Adverse Events Consortium announces initial study results in its global research collaboration to identify genetic markers related to drug induced liver injury 3
... scale-up, these culture chambers produce cell yields ... range and are useful alternatives to ... High mechanical • strength and structural integrity ... • Certified nonpyrogenic and sterilized by gamma ...
Mouse monoclonal antibody to QARS - glutaminyl-tRNA synthetase...
... thermostable DNA polymerase obtained by high level ... in E. coli, Concentration: 5U/ul, Applications: Standard ... Scientific, the world leader in serving science. ... the world healthier, cleaner and safer by ...
ABgene® supplies a 94kDa ultra-pure recombinant thermostable DNA polymerase obtained by high level expression of the Taq DNA polymerase gene in E. coli....
Biology Products: